Create Alert
Watchlist

Everest Organics

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹374Cr
ROE-1.84%
P/E Ratio(TTM)60.25
EPS(TTM)6.39
P/B Ratio5.34
Dividend Yield0.00%
Industry P/E39.61
Book Value72.04
Debt to Equity0.68
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Everest Organics

Everest Organics Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (API) and their intermediaries. It is involved in manufacturing of bulk drugs, such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole. The Company’s API’s products include Pantoprazole Sodium Sesquihydrate USP/BP/EP/IP, Esomeprazole Magnesium Trihydrate-USP/BP/IP/EP, Esomeprazole Magnesium Trihydrate-USP/BP, Esomeprazole Magnesium Dihydrate, Omeprazole Powder-USP / BP/ EP/IP, Omeprazole Magnesium-IP/EP/USP and others. Its intermediates products include 2-Mercapto-5-Methoxy Benzimidazole (Omeprazole-Benzimidazole), 2-Chloro-Methyl-3,5-Dimethyl-4-Methoxy Pyridine HCL (Omeprazole Chloro Compound), Ammonium Sulphate, Sodium Nitrite and others. Its products under development include Sitagliptin, Vildagliptin, Ilaprazole, N-(5-Amino-2-Methylphenyl)-4-(3-Pyridyl)-2-Pyrimidineamine (Imatinib Intermediate), Lanso Sulphide and others. ;
Parent OrganisationEverest Organics Limited
Managing DirectorDr. Srikakarlapudi Sirisha
BSE Symbol524790

Shareholding Pattern

Sep '24
Dec '24
Jan '25
Mar '25
Jun '25
Promoters
60.78%
Retail And Others
39.20%
Other Domestic Institutions
0.02%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
70.47
Neuland Laboratories
NA
(0.00%)
99.87
Jubilant Pharmova
NA
(0.00%)
35.97
Acutaas Chemicals
NA
(0.00%)
60.91